Replies to post #289608 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Barda results check. Now waiting word on second MTA university testing.

"Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants".

[Cognition]

Yes! And how many of those few other drugs have passed phase 2 clinical testing?
And how many of those few other drugs have been tested in IV, Pill, Mouth rinse and foam form without a SINGLE Serious Adverse Effect (SAE)?
How many of those other few drugs have Anti inflammatory properties?
Immune modulating properties?
Is an Antibiotic that kicked another known antibiotics butt when compared. One day of Brilacidin was better than 7 days of Daptomycin...
Etc etc etc